cyramza - ramucirumab solution
(Ramucirumab)Eli Lilly And Company
Usage: Cyramza is a VEGFR2 antagonist for treatment of adults with advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma, metastatic non-small cell lung cancer, metastatic colorectal cancer, and hepatocellular carcinoma with alpha fetoprotein of 400 ng/mL or higher after sorafenib.